We are live on ! Find out more
ROCM

ROCHESTER MEDICAL CORP
ROCM

Delisted

ROCM was delisted on the 13th of November, 2013.

0 hedge funds and large institutions have $0 invested in ROCHESTER MEDICAL CORP in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 680 (-68)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

100% less capital invested

Capital invested by funds: $149M → $0 (-$149M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 68

Holders
Holders Change
-68
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
68
Calls
Puts
Net Calls
Net Calls Change

ROCM Hedge Fund Activity: Q4 2013 in Review

0 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ROCHESTER MEDICAL CORP (ROCM) for Q4 2013, worth a combined $0 — down 100% from $149M a quarter earlier.

Sellers outnumbered buyers: 68 funds closed out of ROCM and 0 opened new positions — a net loss of 68 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was GAMCO Investors, exiting entirely with an estimated $18.9M sold.

  • 0 institutional investors held ROCHESTER MEDICAL CORP (ROCM) as of Q4 2013, down from 68 in Q3 2013.
  • Funds reported $0 of ROCHESTER MEDICAL CORP stock for Q4 2013, down 100% quarter-over-quarter.
  • 0 funds opened new ROCHESTER MEDICAL CORP positions in Q4 2013 and 68 closed out, a net change of -68 holders.
  • The largest ROCHESTER MEDICAL CORP seller in Q4 2013 was GAMCO Investors, an estimated $18.9M sold.

Based on aggregated 13F filings for Q4 2013.